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Abstract 
Purpose: To provide an experimental basis for the anti-diarrheal and anti-oxidant properties of the bark 
extract of Magnolia officinalis Rehd. et Wils., a Chinese traditional herb called magnolol. 
Methods: The effects of magnolol on castor oil-induced diarrhea, small intestinal transit (SIT) in mice 
were investigated. Additionally, the antioxidant activity of magnolol was assessed in mice by the 
following parameters: glutathione (GSH), total antioxidant capacity (T-AOC), antioxidant enzyme 
activities and their gene expression level. 
Results: Compared with diarrhea model control group, magnolol (25, 50, or 100 mg/kg body weight) 
showed significant (p < 0.05) inhibitory activity against castor oil-induced diarrhea in mice. 
Administration of magnolol (25, 50, and 100 mg/kg) also lowered neostigmine-induced SIT acceleration 
to 60.34 ± 5.17, 59.61 ± 7.66, and 54.12 ± 7.27 %, respectively, as against 70.1 ± 6.89 % for 
neostigmine control group. In vivo antioxidant assay results showed that mice treated with magnolol 
exhibited significantly (p < 0.001) higher activities of catalase (CAT), superoxide dismutase (SOD), and 
glutathione peroxidase (GSH-Px) activities in blood, compared to control. Similarly, magnolol proups 
showed significantly higher CAT and SOD and T-AOC activities (p < 0.01) than control in liver tissues. 
The 100 mg/kg magnolol group had significantly higher liver GSH content than normal control group 
(1.01 vs. 0.79 mg/mg protein). At 25 and 50 mg/kg doses, magnolol significantly enhanced gene 
expression levels of CAT (p < 0.01) in liver. 
Conclusion: Findings from this study indicate that magnolol possesses anti-diarrheal activity and is 
probably one of the main anti-diarrhea ingredients of Cortex Magnoliae Officinalis. Magnolol modulation 
of the activity and gene expression of antioxidant enzymes may therefore exert beneficial effects in anti-
oxidant defense.  
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The plant, Magnolia officinalis Rehd. et Wils. also 
known as Magnolia/Houpu, of the family 
Magnoliacea, is one of the most popular 
traditional Chinese medicines. Its pharmaceutical 
properties are found in the bark and root [1]. The 
Chinese name for the herb, ‘houpu’, refers to the 
thick (hou) bark that is the unadorned (pu) 
portion of the plant. The English name for 
medicinal materials of this plant is Cortex 
Magnoliae Officinalis (bark of Magnolia officinalis 
Rehd. et Wils.). This herb has been widely used 
in the treatment of diseases such as thrombotic 
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stroke, typhoid fever, anxiety and nervous 
disturbance, diarrhea, cough and phlegm [2,3]. A 
major bioactive constituent of Cortex Magnoliae 
Officinalis is magnolol (Fig. 1). 
 
Recent investigations have shown that magnolol 
possesses a wide range of physiological 
activities such as anti-tumor [4], anti-microbia [5], 
anti-clastogenic [6] and anti-platelet [7], 
.Moreover, while Cortex Magnoliae Officinalis 
has been used to treat diarrhea in traditional 
Chinese medicine, its anti-diarrhea active 
components are not defined and its mechanism 
of action is still not clear until now. Although 
some researchers have investigated the anti-
oxidant activity of magnolol extracted from 
Cortex Magnoliae Officinalis [8], few of those 
studies were done in vivo. Therefore, the 
objective of this experiment was to investigate 
the anti-diarrhea property of magnolol using the 
castor oil-induced diarrhea mice model and small 
intestinal transit (SIT) and to determine the 
antioxidant activity of magnolol through 
examination of antioxidant enzyme responses at 






The use of animals and the experimental 
procedure were approved (ref. no. 
AWCISA2010012) by the Animal Welfare 
Committee of the Institute of Subtropical 
Agriculture, Chinese Academy of Sciences, and 
the Guidelines for Good Practice in Laboratory 
Animals Feeding and Management was followed 
[9]. Male Kunming mice, 4 - 5 weeks old and 
weighing 20 ± 2 g, were obtained from Hunan 
SLAC Laboratory Animal Company. The animals 
were maintained under standard environmental 
conditions and had access to feed and water ad 
libitum. 
 
Plant material  
 
The plant material tested was the bark of 
Magnolia officinalis Rehd. et Wils. planted in 
Jianghua Yao Autonomous County, Hunan, 
China, in May 2009 at day time. The plant was 
identified by Professor ZH Liu, Department of 
Botany Resources, College of Horticulture and 
Gardening, Hunan Agricultural University, and a 
voucher specimen (Accession no. HNYD-09126) 
was deposited at the Specimen Center of Hunan 
Agricultural University, Changsha, Hunan, China. 
The crude extract was obtained from the bark 
using 60 % ethanol and purified with HP-20 
macroporous absorbing resin. The eluent 
containing magnolol was obtained by fraction 
collection, and the solvent was removed, by 
vacuum concentration, and magnolol obtained 
wby freeze-drying. The purity of the magnolol 
was measured by high performance liquid 
chromatography (HPLC). All doses of magnolol 
in this study were dissolved in 2 %v/v aqueous 
Tween 80 solution for oral gavage administration. 
 
Tests for anti-diarrhea activity 
 
Castor oil-induced diarrhea 
 
Mice fasted for 24 h were randomly divided into 
five groups of ten mice each, diarrhoea was 
induced by administering 0.4 ml of castor oil 
orally to mice [10]. The positive control group 
was orally gavaged with loperamide 
hydrochloride (3 mg/kg), the model control group 
was orally administered saline (20 ml/kg), and 
magnolol-treated groups orally gavaged with 
varying doses of magnolol (25, 50 and 100 
mg/kg BW) 30 min before castor oil 
administration. Each animal was kept a separate 
cage with the floor covered with filter paper. The 
paper was changed every hour. Total number of 
stools, and the number and diameter of loose 
stools were observed within 6 h after 
administration of castor oil. The severity of 
diarrhea was assessed by loose stool incidence 
rate (LSIR), average loose stools grade (ALSG) 
and diarrhea index (DI) [11]. LSIR is the ratio of 
loose stools number to total stools number in 
each animal. Loose stools grade (LSG) 
describes the degree of loose stools pollution on 
the filter papers. The ALSG is the ratio of all 
loose stools grades to loose stools numbers in 
each mouse. Then DI is calculated by multiplying 
LSR by ALSG. 
 
Effect on small intestinal transit 
 
Healthy Kunming mice were randomly divided 
into five groups of ten mice each: the first three 
groups were administered magnolol orally at the 
doses of 25, 50 and 100 ml/kg, respectively; the 
other two groups were neostigmine group and 
normal (control) group, respectively, and both 
were administered saline (20 ml/kg). All the mice 
received magnolol or saline treatment by oral 
gavage once daily for 4 days. On day 4, 30 min 
after oral treatment (except for normal control 
group), all the groups received 0.15 mg/kg 
neostigmine by intraperitoneal (ip) injection. 
Twenty minutes later, 5 % charcoal meal (10 
ml/kg) was given to each mouse by intragastric 
gavage. After 20 min, all the animals were 
sacrificed by cervical dislocation and the small 
intestines were isolated immediately. The 
distance travelled by the charcoal meal from the 
pylorus and the total length of the intestine were 
Pang et al 
Trop J Pharm Res, February 2013;12 (1): 
 
87 
measured in cm. Small intestinal transit (SIT) 
was expressed as the percent (%) of the 
distance traveled by the charcoal meal relative to 
the total length of the small intestine [12]. 
 
Tests for antioxidant activity 
 
Animals and treatment 
 
Kunming male mice were randomly divided into 
five groups (n = 8): blank control group treated 
with 2 % aqueous Tween 80 solution, positive 
control group treated with 50 mg/kg vitamin E 
dissolved in 2 % aqueous Tween 80 solution, 
three magnolol-treated groups administered 25, 
50 or 100 mg/kg doses, respectively. All the 
animals were administered the respective doses 
via oral gavage once daily for 14 consecutive 
days. 
 
On the 14th d of oral administration, all mice 
were treated with light ether anesthesia. 
Thereafter, the blood was collected via 
retroorbital bleeding into heparin treated tubes to 
obtain blood plasma samples for analysis of 
antioxidant parameters. The mice were sacrificed 
by cervical dislocation after bleeding. The liver 
was rapidly removed under aseptic condition, 





The activity of glutathione peroxidase (GSH-Px), 
total superoxide dismutase (T-SOD) and 
catalase (CAT) in plasma and liver, as well as 
glutathione (GSH) and total antioxidative 
capacity (T-AOC) in liver, were measured using 
commercially available kits (Jiancheng Biology 
Company., China). 
 
Gene expression analysis 
 
Total RNA from liver tissue was isolated using 
TRIzol reagent (Invitrogen, USA). Thereafter, 
cDNA synthesis from liver was performed with 
RevertAid First Strand cDNA Synthesis Kit 
(Fermentas, USA). Primers for CAT gene 
(forward primer CCGAGTCTCTCCATCAGGTTT 
C; reverse primer CGGTCTTGTAATGGAACTTG 
CA), GSH-Px gene (forward primer CTGGCAT 
TGGCTTGGTGAT; reverse primer GTGGAAAG 
GCATCGGGAAT), copper-zinc superoxide 
dismutase (Cu/Zn-SOD) gene (forward primer 
AAGCGGTGAACCAGTTGTGTT; reverse primer 
GGCCACCATGTTTCTTAGAGTGA), manga-
nese superoxide dismutase (Mn-SOD) gene 
(forward primer CTGGAGGCTATCAAGCGT 
GACT; reverse primer CCTGATTAGAGCAG 
GCAGCAAT), extracellular superoxide 
dismutase (EC-SOD) gene (forward primer GTG 
GCTCTGTCACCATGTCAAAT; reverse primer 
CGTCCTAGCTCCATCCAGATCT) and β-actin 
gene (forward primer AGAGGGAAATCGTGC 
GTGAC; reverse primer CAATAGTGATGAC 
CTGGCCGT) were designed using Premier 5 
software.. 
 
A 10 µl reaction mixture containing 5 µL 2 × 
Power SYBR Green PCR Master Mix (Applied 
Biosystems, USA), 0.1 µL cNDA template, 0.3 µL 
forward primer (1 µmol/L), 0.3 µL reverse primer 
(1 µmol/L) and 4.3 µL water, was conducted on 
an ABI 7900 HT fast real-time PCR system 
(Applied Biosystems, USA) using the following 
cycling conditions: 95°C for 10 s holding and 40 
cycles of 95 °C for 20 s, 60 °C for 30 s. 
Quantification of the PCR products of all samples 
was evaluated in comparison with the PCR 
product to β-actin. The relative changes of 
mRNA expression ratio determined from qPCR 
were calculated according to the 2△CT method, 




The data were expressed as mean ± SD and 
analyzed statistically using ANOVA, followed by 
Dunnett’s comparisons test using SAS software 
(Version 8, SAS Institute Inc., Cary, NC, USA). 
Differences at p < 0.05 were considered to be 
statistically significant, while p < 0.01 and p < 




Extraction of magnolol 
 
The crude extraction rate of magnolol reached 
86.8% using ethanol extraction. After the 
purification with HP-20 macroporous absorbing 
resin, the purity of magnolol was 96.7% as 
indicated by HPLC analysis. 
 
Inhibitory effect of magnolol on castor-oil-
induced diarrhea 
 
The results of LSR, ALST and DI are shown in 
Table 1. ALSG did not differ between model 
control, positive control and magnonol treatment 
groups. The LSR of model control mice was 
higher (p < 0.05) than that of magnolol groups, 
while LSR of positive control group was lower (p 
< 0.001) than that of the latter. Model control 
group had significantly higher DI than magnolol 
treatment groups, while positive control group 
had the least DI. 
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Table 1: Effect of magnolol on diarrhea induced by castor oil in mice  
 
Group LSR ALSG DI 
Model control 0.83±0.09 1.67±0.13 1.38±0.16 
Positive control 0.37±0.08 1.67±0.12 0.62±0.15 
Magnolol (25mg/ml) 0.69±0.12##*** 1.64±0.10 1.13±0.18#*** 
Magnolol (50mg/ml) 0.72±0.08#*** 1.60±0.16 1.15±0.18#*** 
Magnolol (100mg/ml) 0.65±0.06###*** 1.66±0.11 1.08±0.12##*** 
Model control = castor oil-induced-diarrhea model; Positive control: castor oil-induced-diarrhea model + 
loperamide hydrochloride administration; #p < 0.05, ##p < 0.01, ###p < 0.001, compared with model 
control; *p < 0.05, **p < 0.01, ***p < 0.001, compared with positive control group 
 
Table 2: Effect of magnolol on small intestine transit of mice  
 
Group  Small intestine length 
(cm) 
Carbon promote distance 
(cm) 
Small intestinal transit 
(SIT) 
(%) 
Normal control 51.8±5.65 24.9±5.11 47.9±7.41 
Neostigmine 52.3±4.08 36.6±4.25 70.1±6.89 
Magnolol (25mg/kg) 49.8±6.40 30.0±4.29** 60.3±5.17##* 
Magnolol (50mg/kg) 47.7±5.33 28.5±5.30*** 59.6±7.66##** 
Magnolol (100mg/kg) 47.5±4.62 25.6±3.50*** 54.1±7.27*** 
Normal control = normal saline; #p < 0.05, ##p < 0.01, ###p < 0.001, compared with normal control; *p < 
0.05, **p < 0.01, ***p < 0.001, ompared with neostigmine group 
 
Effect of magnolol on small intestinal transit 
 
There were no significant differences in small 
intestine length among the groups (Table 2); 
however, neostigmine group had higher (p < 
0.01) carbon promotion distance than the 
magnolol groups. Under normal conditions, the 
SIT rate of the charcoal meal was 47.88 ± 7.41 
%. Neostigmine increased SIT by about 46 % 
over that of normal control group. After 
administration of magnolol (25, 50, and 100 
mg/kg), SIT rate decreased to 60.34 ± 5.17, 
59.61 ± 7.66, and 54.12 ± 7.27% in the magnolol 
groups, respectively, as compared with 
neostigmine group. Administration of magnolol 
suppressed the SIT induced by neostigmine in a 
dose-dependent manner. 
 
Effect of magnolol on activity of blood 
antioxidation enzymes 
 
The activities (U/mg prot) of CAT, GSH-PX and 
T-SOD of mice gavaged with different doses of 
magnolols were all higher (p < 0.001) than those 
of normal control mice (Fig 1). Mice treated with 
magnolol had higher GSH-PX (p < 0.001) 
activities than positive control mice. 
 
Effect of magnolol on liver antioxidation 
status 
 
Normal control mice had lower (p < 0.01) CAT 
activities than magnolol-gavaged mice, which in 
turn showed higher CAT activity than positive 
control mice (Table 3). Mice gavaged with 
different doses of magnolols had higher T-SOD 
activity (p < 0.001) than normal control mice. 
Magnolol (25mg/ml) mice had lower (p < 0.01) 
GSH-PX activity than positive control mice, while 
magnolol (100 mg/ml) mice had higher (p < 0.05) 
GSH-PX activity than normal control mice. GSH 
of normal control mice was lower (p < 0.05) than 
that of mice treated with a high dose of magnolol 
(100 mg/kg). Normal control mice had lower (p < 
0.01) T-AOC than all magnolol groups. Magnolol 
(50 mg/kg) produced higher (p < 0.05) T-AOC 





























Fig 1.  Effect of magnolol on activity of blood 
antioxidant enzymes in mice (n=8). 
Normal control = normal saline; positive control = 
vitamin E; #p < 0.05, ##p < 0.01, ###p < 0.001, 
compared with normal control; *p < 0.05, **p < 
0.01, ***p < 0.001, compared with positive control  
: Normal control; : Positive control; : Magnolol 
25; : Magnolol 50; : Magnolol 100. 
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Normal control 7.73±1.31 44.3±4.77 167.6±13.06 0.79±0.07 0.60±0.09 
Positive control 10.19±1.25 56.9±4.97 201.3±14.84 0.89±0.09 0.72±0.08 
Magnolol (25mg/kg) 13.14±2.36## 54.5±2.70### 174.6±19.50** 0.84±0.16 0.87±0.13## 
Magnolol (50mg/kg) 15.36±4.83###** 54.7±5.05### 185.8±7.01 0.86±0.10 0.93±0.13###* 
Magnolol (100mg/kg) 17.02±3.81###*** 54.9±5.84### 189.7±13.61# 1.01±0.27# 0.92±0.23### 
 
Normal control = normal saline; positive control = vitamin E; #p < 0.05, ##p < 0.01, ###p < 0.001, compared with 
normal control; *p < 0.05, **p < 0.01, ***p < 0.001, compared with positive control 
 
Table 4: Effect of magnolol on gene expression of anti-oxidant enzymes in liver (n = 8) 
 
Groups CAT GSH-Px Cu/Zn-SOD Mn-SOD EC-SOD 
Normal control 
0.32±0.02 4.49±0.69  1.28±0.19 0.060±0.015 0.002±0.0011 
Positive control 
0.42±0.06 7.08±0.56  1.55±0.14 0.074±0.018 0.002±0.0010 
Magnolol 25 
0.43±0.08 4.76±0.75*** 1.39±0.29 0.055±0.009 0.005±0.0016##** 
Magnolol 50 
0.60±0.08###** 4.86±0.30*** 1.33±0.17 0.064±0.014 0.006±0.0014###*** 
Magnolol 100 
0.61±0.06###** 4.87±0.68*** 1.51±0.18 0.065±0.013 0.004±0.0015 
Normal control = normal saline; positive control = vitamin E; #p < 0.05, ##p < 0.01, ###p < 0.001, compared with 
normal control; *p < 0.05, **p < 0.01, ***p < 0.001, compared with positive control. 
 
Effect of magnolol on gene expression of 
anti-oxidant enzymes in liver 
 
CAT had higher gene expression level (Table 4) 
in mice gavaged with magnolol than in normal 
control (p < 0.001) and positive control mice (p < 
0.01). Mice treated with different doses of 
magnolols had higher (p < 0.001) GSH-PX gene 
expression than positive control mice. Gene 
expression of Cu/Zn-SOD and Mn-SOD did not 
differ among groups. Though expression of EC-
SOD in all groups was very low, mice gavaged 
with lower doses of magnolol (25 and 50 mg/kg) 
had higher (p < 0.01) EC-SOD expression level 




Castor oil-induced diarrhea is as a result of the 
action of ricinoleic acid formed from the 
hydrolysis of its triglyceride in the duodenum by 
pancreatic lipase. The ricinoleic acid produces 
irritation and inflammation of the intestinal 
mucosa and also stimulates intestinal 
hypermotility and hypersecretion. These series of 
action lead to diarrhea after the administration of 
castor oil [13,14]. The fact that the extract 
exhibited inhibitory effect against the castor oil-
induced diarrhea implies that this property could 
contribute to the anti-inflammatory, anti-
hypermotility or anti-hypersecretion activities of 
the plant. 
 
In some previous studies, magnolol was found to 
exhibit anti-inflammatory activities. Wang et al 
observed that magnolol inhibited mouse hind-
paw oedema induced by carrageenan and 
polymyxin B, and reversed passive Arthus 
reaction, and it was proposed that the anti-
inflammatory and analgesic action of magnolol is 
dependent on reducing the level of eicosanoid 
mediators[15]. An inhibitory action of magnolol 
on the production of leukotriene (LT) C4 and 
LTB4, important lipid mediators in allergy and 
inflammation was observed in basophilic 
leukemia (RBL)-2H3 cells of intact rat [16]. It was 
also found that magnolol inhibits TNF-α-induced 
nuclear translocation of NF-κB p65 and thereby 
suppresses expression of VCAM-1, resulting in 
reduced adhesion of leukocytes [17]. These data 
suggest that magnolol acts as a potent anti-
inflammatory agent both in vitro and in vivo. 
 
Magnolol has been found to have muscle 
relaxing effect. Teng et al reported that magnolol 
relaxed vascular smooth muscle in rat thoracic 
aorta [18] and Ko et al found magnolol had 
inhibitory actions on smooth muscle contraction 
in porcine trachea [19]. Recent research showed 
magnolol reduced vascular contraction by 
inhibiting the RhoA⁄Rho kinase pathway in 
endothelium-denuded rat aorta [20]. In this study, 
magnolol significantly reduced hyperactive 
intestinal transit induced by neostigmine, which 
might be related with their possible relaxing 
effect on mouse intestinal smooth muscle. 
Furthermore, acetylcholine stimulates 
89 
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gastrointestinal motility and neostigmine is an 
inhibitor of acetylcholinesterase (AChE) which 
metabolizes acetylcholine to inactive metabolites. 
By enhancing enteric acetylcholine, neostigmine 
exerts gastrointestinal motility stimulating action. 
This suggests that the inhibition of neostigmine-
induced hyper-intestinal movement is possibly 
related to the effect of magnolol upon 
acetylcholine system in small intestine; this 
possibility needs to be studied further.  
 
Diarrhea occurs when bowel contents are 
passed without being sufficiently digested or 
absorbed due to accelerated enteric juice 
secretion or peristalsis after stimulation of the 
enteric tract [21]. Therefore, although there might 
be other mechanisms for inhibiting diarrhea and 
further investigations are necessary, one reason 
for the anti-diarrhea effect of magnolol may be 
due to the inhibition of excessively accelerated 
movement of the small intestine. 
 
In addition, Bian et al indicated that magnolol can 
inhibit the contraction of isolated colonic muscle 
strips in Guinea pig by blocking the voltage 
dependent calcium channel and inhibiting 
calcium release from the sarcolemmal 
membrane [22]. Consequently, magnolol may be 
considered a putative calcium antagonist or 
calcium channel blocker. Calcium is involved in 
secretory diarrhea by modulating secretion of 
chloride or potassium, and gut motility also 
seems to be mediated by calcium flux [23]. As 
calcium antagonism, magnolol could be 
speculated to have both anti-motility and anti-
secretory effects, which might be helpful in 
inhibiting diarrhea. Taken as a whole, the anti-
diarrheal activity of magnolol may be an 
integration of multi-mechanisms. 
 
The changes in antioxidant enzyme activities can 
reflect the anti oxidation status in animal. In this 
study, CAT, GSH-Px and SOD activities in the 
blood plasma and liver of Kunming mice 
significantly increased by treatment with 
magnolol, suggesting that they could provide 
more powerful antioxidant protection. On the 
other hand, treatment with magnonlol caused a 
remarkable increase in the gene-expression 
levels of CAT and EC-SOD. At the same time the 
gene expression levels of GSH-Px and CuZn-
SOD in magnolol-treated mice were higher than 
that in normal control mice. Therefore, 
administration of magnolol to Kuming mice 
induced the increment in CAT, GSH-Px and T-
SOD activities possibly by up-regulating the 
gene-expression level of CAT, GSH-Px and T-
SOD, which being ascribed to the antioxidant 
action of magnolol. 
Tissue GSH plays a central role in antioxidant 
defense by detoxifying ROS directly or in a GSH-
Px catalyzed mechanism. Magnolol has been 
found to have a protective effect against D-
galactosamine-induced hepatotoxicity, which was 
used as an alternate model to oxidative stress, 
acting by inhibiting intracellular GSH depletion 
[24]. Our present study also showed magnolol 
increased GSH of normal mice liver. This 
increase in the GSH level may be due to an 
increased antioxidant capacity of liver and body. 
 
Total antioxidant capacity (T-AOC) reflects the 
capacity of the non-enzymatic antioxidant 
defense system. In this study, magnolol 
administration greatly elevated the total 
antioxidant capacity in the livers. Magnolol 
treatment at a dose of 50 mg/kg had the highest 
increase in total antioxidant capacity in all tested 
groups. Above results showed that magnolol 
might increase the activities of both the non-
enzymatic and enzymatic antioxidant defense 





The present results have shown that magnolol of 
Cortex Magnolia Officinalis possesses anti-
diarrheal and anti-oxidation activities. Further 
studies, however are needed to identify its 
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